BNP Paribas Financial Markets’s Procept Biorobotics PRCT Stock Holding History

BNP Paribas Financial Markets’s Portfolio PRCT Stock Details PRCT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$9.03M	Buy	400,044 +201,894	+102%	+$5.05M	﹤0.01%	1708
2026 Q1	$4.96M	Sell	198,150 -9,826	-5%	-$277K	﹤0.01%	2028
2025 Q4	$6.54M	Buy	207,976 +115,996	+126%	+$3.85M	﹤0.01%	1866
2025 Q3	$3.28M	Buy	91,980 +48,281	+110%	+$2.2M	﹤0.01%	2266
2025 Q2	$2.52M	Sell	43,699 -21,942	-33%	-$1.24M	﹤0.01%	2322
2025 Q1	$3.82M	Sell	65,641 -77,185	-54%	-$5.27M	﹤0.01%	1975
2024 Q4	$11.5M	Buy	+142,826	New	+$12.2M	0.01%	1273
2022 Q4	–	Sell	-18,454	Closed	-$765K	–	4468
2022 Q3	$765K	Buy	+18,454	New	+$736K	﹤0.01%	2685

Other funds holding PRCT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BNP Paribas Financial Markets's PRCT Position: Q2 2026 in Review

BNP Paribas Financial Markets increased its Procept Biorobotics (PRCT) stake by 102% in Q2 2026, buying an estimated $5.05M and bringing the position to 400,044 shares worth $9.03M. The position accounts for ﹤0.01% of the portfolio, ranked #1708.

BNP Paribas Financial Markets first reported a position in PRCT in Q3 2022 and has held it in 8 quarters since. The position peaked at $11.5M in Q4 2024. 254 funds tracked by Wall St. Rank hold PRCT as of Q2 2026.

BNP Paribas Financial Markets held 400,044 shares of Procept Biorobotics worth $9.03M as of Q2 2026.
BNP Paribas Financial Markets bought 201,894 Procept Biorobotics shares in Q2 2026, an estimated $5.05M.
Procept Biorobotics made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #1708 holding.
BNP Paribas Financial Markets first reported a position in Procept Biorobotics in Q3 2022 and has held it in 8 quarters since.
BNP Paribas Financial Markets's Procept Biorobotics position peaked at $11.5M in Q4 2024.
254 funds tracked by Wall St. Rank held Procept Biorobotics as of Q2 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.